Image

Development of Transdiagnostic Single-session Treatment

Development of Transdiagnostic Single-session Treatment

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this clinical trial is to test a single session treatment program in primary care patients with anxiety and/or depression and/or stress-related issues. The main questions it aims to answer is:

  • Will the transdiagnostic treatment program decrease symptoms of depression/anxiety/stress?
  • Will the transdiagnostic treatment program decrease transdiagnostic risk factors?
  • Will the transdiagnostic treatment program decrease the measured risk factors equally?
  • Will the transdiagnostic treatment program impact patients with anxiety, depression or stress disorders equally?
  • Will the transdiagnostic treatment program have long term (6 months post-treatment) effect on transdiagnostic risk factors?
  • Will the transdiagnostic treatment program have long term (6 months post-treatment) effect on anxiety, depression, or stress-symptoms?
  • Have the participants been able to generalize the skills taught in the program(qualitative)?
  • Within group that were treated with single-session treatment and recieved additional care before follow-up, was there a difference in outcome?

Description

The study investigates the effect of a single-session, 4 hour, transdiagnostic treatment for primary care patientst with depression, anxiety or stress.

The treatment includes, interoceptive exposure, behavioral activation, mindfulness, defusion and psycho-education about emotions.

The study is conducted in a clinical setting in northern sweden and follows up results at 3 weeks and 6 months post treatment.

Eligibility

Inclusion Criteria:

  • Meet the criteria for anxiety, mood disorder, or stress diagnosis
  • Symptoms are mild to moderate in severity

Exclusion Criteria:

  • Already in ongoing psychotherapy
  • Within a month commenced pharmaceutical treatment that will likely impact mood or psychological functioning and is not deemed to be on a stable dose
  • Has a comorbid personality disorder
  • Has a risk of suicide deemed other than low
  • Has other severe psychological disorders outside the scope of primary care
  • Is in a severely stressful social situation deemed incompatible with psychotherapy

Study details
    Anxiety Disorders
    Depression
    Stress Disorder

NCT05784259

LuleƄ Tekniska Universitet

27 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.